THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Takeda and Halozyme collaborate on vedolizumab and ENHANZE® drug-delivery technology
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Takeda granted exclusive access to Halozyme’s ENHANZE® technology for use with vedolizumab under a global collaboration and license agreement.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- Osaka; Cambridge, Japan; United States
- Source checked
- September 24, 2026
FOLLOW THE STORY